Long COVID Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Long COVID clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 2

Antiviral Clinical Trial for Long Covid-19

Long COVID
Icahn School of Medicine at Mount Sinai90 enrolled1 locationNCT06511063
Recruiting

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Long COVIDMajor Depressive DisorderMajor Depressive Episode
Centre for Addiction and Mental Health90 enrolled1 locationNCT06086366
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Traumatic Brain InjuryEhlers-Danlos SyndromePost-Acute COVID-19 Syndrome+41 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Heart FailureLong COVID SyndromeMyocarditis+2 more
Johann Wolfgang Goethe University Hospital6,000 enrolled1 locationNCT04444128
Recruiting
Phase 2

A Study to Examine Anktiva for the Treatment of COVID-19.

Long COVIDLong COVID SyndromeLong Covid 19
ImmunityBio, Inc.40 enrolled1 locationNCT07123727
Recruiting
Early Phase 1

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

ObesityMultiple SclerosisLong COVID+4 more
University of Chicago30 enrolled1 locationNCT06171152
Recruiting
Not Applicable

Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.

AnxietyLong Covid 19Emotional Disorder+2 more
Instituto de Investigación Sanitaria Aragón90 enrolled2 locationsNCT06928480
Recruiting

Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

Long COVIDLong COVID Syndrome
Instituto Nacional de Rehabilitacion20 enrolled1 locationNCT06864156
Recruiting
Not Applicable

Effectiveness of Non-invasive Neuromodulation in Patients With Long-COVID

Post-Acute COVID-19 SyndromeLong COVID
Universidad Rey Juan Carlos44 enrolled1 locationNCT06456502
Recruiting
Phase 2

tDCS in the Management of Post-COVID Disorders

Long COVID
Universidade Federal de Pernambuco48 enrolled2 locationsNCT06074848